Koyfin Home > Directory > Health Care > Abbott Laboratories > Debt Repaid

Abbott Laboratories Debt Repaid Chart (ABT)

Abbott Laboratories annual/quarterly Debt Repaid from 2010 to 2020.
  • Abbott Laboratories Debt Repaid for the quarter ending September 09, 2020 was $-1,330m a -119.40% increase of 1,588m year over year
  • Abbott Laboratories Debt Repaid for the last 12 months ending September 09, 2020 was $-4,250m a 19.04% decrease of -809m year over year
  • Abbott Laboratories Annual Debt Repaid for 2019 was $-3,441m a -262.07% increase of 9,018m from 2018
  • Abbott Laboratories Annual Debt Repaid for 2018 was $-12,459m a 22.27% decrease of -2,775m from 2017
  • Abbott Laboratories Annual Debt Repaid for 2017 was $-9,684m a 81.63% decrease of -7,905m from 2016
Other Cash Flow Metrics:
  • Abbott Laboratories Cash Flow from Operations for the quarter ending September 09, 2018 was $2,183m a 8.15% increase of 178m year over year
  • Abbott Laboratories Levered Free Cash Flow (FCF) for the quarter ending September 09, 2018 was $1,647m a 6.17% increase of 102m year over year
  • Abbott Laboratories Total Revenue for the quarter ending December 12, 2018 was $7,765m a 4.83% increase of 375m year over year
View Chart On Koyfin

Quarterly ABT Debt Repaid Data

09/2020$-1,330m
06/2020$-1m
03/2020$-1m
12/2019$-2,918m
09/2019$-2m
06/2019$-21m
03/2019$-500m
12/2018$-4,180m
09/2018$-999m
06/2018$-1,301m

Annual ABT Debt Repaid Data

2019$-3,441m
2018$-12,459m
2017$-9,684m
2016$-1,779m
2015$-1,338m
2014$-577m
2013$-303m
2012$-11,071m
2011$-4,977m
2010$-1,878m